Sponsored
Novo Nordisk CEO to step down amid market challenges and stock plunge
Posted
Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy, along with Eli Lilly's Zepbound gaining market share, contributed to the decision.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Dr Reddy's receives two USFDA observations for New York API facility
Dr. Reddy's Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483...
UML a defining party based on people’s multi-party democracy: General Secretary Pokharel
KATHMANDU: General Secretary of the CPN-UML, Shankar Pokharel, has asserted that the UML has...
Chad: Ex-PM Masra arrested over deadly clashes
Chad's former Prime Minister, Succes Masra, was arrested on Friday, accused of inciting hatred...
Indian tourist jailed for molesting 12-year-old minor in Singapore
In Singapore, Pramender, an Indian tourist, was convicted for molesting a 12-year-old girl at a...